Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-148-4
CAS number: 25637-99-4
The following information is available for the short-term toxicity to fish endpoint:Graves, W. C. and Swigert, J. P. (1997). Hexabromocyclododecane (HBCD): A 96-hour flow-through acute toxicity test with the Rainbow Trout (Oncorhynchus mykiss). Report no.: 439A-101.Report date: 1997-06-03.Anon (1978). The acute toxicity of HBCD to the Bluegill Sunfish, Lepomis macrochirus Rafinesque. Report no.: Proj. No. 11506-03-77. Report date: 1978-10-03.Ronisz, D., Farmen Finne, E., Karlsson, H. and Förlin, L. (2004). Effects of the brominated flame retardants hexabromocyclododecane (HBCDD), and tetrabromobisphenol A (TBBPA), on hepatic enzymes and other biomarkers in juvenile rainbow trout and feral eelpout. Aquatic Toxicology (2004), Vol. 69, pp.229-245.Graves (1997) was selected as the key study for the endpoint based upon the reliability score of according to the criteria of Klimisch et al., 1997). Anon (1978) and Ronsiz et al. (2004) were allocated a reliability score of 3 and 4 respectively according to the same criteria.
An early dongle study reported the 96 hour LC50
of HBCDD in bluegill sunfish as >100 mg/L, the highest dose tested.
In a guideline/GLP-compliant study, HBCDD was
not acutely toxic to rainbow trout at the limit of the gamma
stereoisomer’s solubility. HBCDD’s
96 hour LC50, no mortality
concentration and NOEC were all greater than the gamma stereoisomer’s
water solubility. The
highest nominal dose tested was twice that water solubility. Nominal
test concentrations were 0, 1.5, 2.2, 3.2, 4.6 and 6.8 µg/L and
corresponded to mean measured concentrations (HPLC with UV/VIS detector)
of 0, 0.75, 1.5, 2.3, 2.3 and 2.5 µg/L, respectively (Graves et al.,
1997). A composite of three manufacturers' commercial products was used
as test substance in this study. The dose levels in the study were based
on the water solubility of HBCD (approximately 3.4 µg/L), and determined
via quantiation on the gamma diastereomer. The alpha and beta
diastereomers were not quantifiable at HBCDD test levels based on the
water solubility of the gamma diasteromer. Thus, the HBCDD commercial
product was not acutely toxic to rainbow trout at nominal concentrations
of 6.8 µg/L. Correcting for content of the gamma diasteromer, the 96
hour LC50 in rainbow trout was >8.5
µg/L. The lack of toxicity is consistent with results from the early non
GLP study in sunfish.
Single or two intraperitoneal injections of
50 or 500 mg HBCDD/kg to juvenile rainbow apparently did not induce
mortality over a 28 day period. A single IP injection of 50 or 500 mg/kg
did not alter the liver to body weight ratio when tested at 5 days
post-injection. Induction of hepatic glutathione reductase, catalase,
EROD or GST was not observed at 5 days. Similarly no effects were seen
in eelpout (a marine species) at either dose when examined at 5 days
post-injection. The test substance was a commercial HBCDD product. The
lack of toxicity in this study at doses of 50 and 500 mg/kg injected IP
further supports that HBCDD is not toxic via administration in water at
concentrations approximating the water solubility of the gamma
diasteromer or when substantially higher concentrations (up to 100 mg/L)
are added to water.
Thus HBCDD was not acutely toxic when tested
in freshwater and marine fish species.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again